Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Higher heart rate has been associated with an adverse prognosis, but most prior studies focused on individuals with known cardiovascular disease or examined a limited number of outcomes. We sought to examine the association of baseline heart rate with both fatal and nonfatal outcomes during 2 decades of follow‐up. Methods and Results: Our study included 4058 Framingham Heart Study participants (mean age 55 years, 56% women). Cox models were performed with multivariable adjustment for clinical risk factors and physical activity. A total of 708 participants developed incident cardiovascular disease (303 heart failure, 343 coronary heart disease, and 216 stroke events), 48 received a permanent pacemaker, and 1186 died. Baseline heart rate was associated with incident cardiovascular disease (hazard ratio [HR] 1.15 per 1 SD [11 bpm] increase in heart rate, 95% CI 1.07 to 1.24, P =0.0002), particularly heart failure (HR 1.32, 95% CI 1.18 to 1.48, P <0.0001). Higher heart rate was also associated with higher all‐cause (HR 1.17, 95% CI 1.11 to 1.24, P <0.0001) and cardiovascular mortality (HR 1.18, 95% CI 1.04 to 1.33, P =0.01). Spline analyses did not suggest a lower threshold beyond which the benefit of a lower heart rate abated or increased. In contrast, individuals with a higher heart rate had a lower risk of requiring permanent pacemaker placement (HR 0.55, 95% CI 0.38 to 0.79, P =0.001). Conclusions: Individuals with a higher heart rate are at elevated long‐term risk for cardiovascular events, in particular, heart failure, and all‐cause death. On the other hand, a higher heart rate is associated with a lower risk of future permanent pacemaker implantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563 · cited 1×
“Total cholesterol, mg/dL 200 (38) 206 (37) 208 (38) 212 (41)”
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Ingwall, J. S., & Weiss, R. G. (2004) · Circulation Research · doi:10.1161/01.res.0000137170.41939.d9 · Cited by 604 · cited 1×
“Heart rate, beats per minute 52 (4) 61 (2) 68 (3) 80 (8) Body mass index, kg/m(2) 25.”
Influence of Heart Rate on Mortality in a French Population: Role of Age, Gender, and Blood Pressure
Benetos, A., Rudnichi, A., Thomas, F., Safar, M., & Guize, L. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.44 · Cited by 356
Heart rate as marker of sympathetic activity
Grassi, G., Vailati, S., Bertinieri, G., Seravalle, G., Stella, M. L., DellʼOro, R., & Mancia, G. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00010 · Cited by 279
Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men.
Shaper, A. G., Wannamethee, G., Macfarlane, P. W., & Walker, M. (1993) · Heart · doi:10.1136/hrt.70.1.49 · Cited by 196
Jouven, X., Empana, J. P., Escolano, S., Buyck, J. F., Tafflet, M., Desnos, M., & Ducimetière, P. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.08.071 · Cited by 175 · cited 2×
“Antihypertensive treatment, n (%) 81 (9) 120 (11) 140 (14) 229 (22)”
Cited by
Aune, D., Giovannucci, E., Boffetta, P., Fadnes, L. T., Keum, N., Norat, T., Greenwood, D. C., Riboli, E., Vatten, L. J., & Tonstad, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw319 · Cited by 2,419
Graudal, N. A., Hubeck-Graudal, T., & Jurgens, G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004022.pub4 · Cited by 620
Zhang, D., Shen, X., & Qi, X. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.150535 · Cited by 322
Aune, D., Sen, A., ó'Hartaigh, B., Janszky, I., Romundstad, P. R., Tonstad, S., & Vatten, L. J. (2017) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.004 · Cited by 284
Zhang, D., Wang, W., & Li, F. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.160050 · Cited by 120
Metadata
- Authors
- Ho, J. E., Larson, M. G., Ghorbani, A., Cheng, S., Coglianese, E. E., Vasan, R. S., & Wang, T. J.
- Venue
- Journal of the American Heart Association
- Published
- 2014-05-22
- Volume
- 3
- Issue
- 3
- Pages
- e000668-e000668
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2134240217
- Cited by
- 145
- References
- 7
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study. https://app.cochat.ai/papers/10.1161/jaha.113.000668
- The paper
- Ho, J. E., Larson, M. G., Ghorbani, A., Cheng, S., Coglianese, E. E., Vasan, R. S., & Wang, T. J. (2014). Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.113.000668
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.